US OTC: MDIT

How many employees work at MEDITE Cancer Diagnostics?

MEDITE Cancer Diagnostics, Inc. (MDIT) has approximately 309 total employees worldwide as of March 2026, according to Revelio Labs workforce intelligence data. MEDITE Cancer Diagnostics’s total headcount has grown 80.9% from 171 employees in 2023 to 309 in 2026.

Data source: Revelio LabsCoverage: Global workforce, 2023–2026Published August 2026

Is MEDITE Cancer Diagnostics hiring right now?

Yes, MEDITE Cancer Diagnostics is actively hiring. MEDITE Cancer Diagnostics had 58 active job postings in 2026, a 109.3% increase from 2025 — see job openings & hiring trends.

About MEDITE Cancer Diagnostics’s Workforce

MEDITE Cancer Diagnostics, Inc. (MDIT) is a Healthcare and Wellness Services company that employs 309 people worldwide as of March 2026. It is the 7th-largest by headcount among its peers. Founded in 1998, the company is headquartered in Orlando, Florida and trades on the US OTC.

MEDITE Cancer Diagnostics's workforce has grown 80.9% from 2023 to 2026, up 4.4% year over year in 2026. It fell to a low of 168 in 2023 Q3 before recovering. Its workforce is concentrated most in North America (70.9%), followed by Western Europe (15.7%) and East Asia (4.4%).

MEDITE Cancer Diagnostics's functional groups are Finance and Operations (38.7%), Engineering (36.7%), and Sales and Marketing (24.6%), with Engineering growing fastest (up 12.8%). The average salary is $124,661, ranging from a median of $128,000 in North America to $9,000 in Southeast Asia, up 2.1% year over year in 2026.

MEDITE Cancer Diagnostics's active job postings rose 109.3% in 2026 to 58, with new postings per month climbing from 7 in 2023 to 24 in 2026. Overall employee sentiment is negative and declining.

Sourced from Revelio Labs workforce data.

Ticker
US OTC: MDIT
Headquarters
Orlando, Florida
Founded
1998
Industry
Healthcare and Wellness Services
Employees
309
YoY
+4.4% (+81)

Unlock hiring rate, attrition rate, and 12 additional workforce metrics for MEDITE Cancer Diagnostics. Compare to peers, export the dataset, and access the full quarterly history.

Unlock Metrics

MEDITE Cancer Diagnostics Annual Employee Count (2023-2026)

Interactive chart of MEDITE Cancer Diagnostics annual worldwide employee count from 2023 to 2026.
  • MEDITE Cancer Diagnostics had 309 employees in 2026, a 4.4% increase (+81) from 2025.
  • MEDITE Cancer Diagnostics had 285 employees in 2025, a 5.1% increase (+73) from 2024.
  • MEDITE Cancer Diagnostics had 212 employees in 2024, a 0.1% increase (+38) from 2023.
  • MEDITE Cancer Diagnostics had 174 employees in 2023, a 2.3% increase (+13) from 2022.

MEDITE Cancer Diagnostics's total workforce has grown from 171 employees in 2023 to 309 in 2026.

MEDITE Cancer Diagnostics, Inc. quarterly employee count

YearQtrEmployeesYoY ChangeYoY %
2026Q1309+81+4.4%
2025Q4285+73+5.1%
2025Q3268+73+7.6%
2025Q2248+47+1.6%
2025Q1228+41+2.5%
2024Q4212+38+0.1%
2024Q3195+27+2.5%
2024Q2201+30+6.9%
2024Q1187+23+6.2%
2023Q4174+13+2.3%
2023Q3168+8+0.8%
2023Q2171+22+5.8%

See MEDITE Cancer Diagnostics's complete headcount history, including quarterly breakdowns.

Get the Data

MEDITE Cancer Diagnostics Employee Count by Region (2026)

North America accounts for the largest share of MEDITE Cancer Diagnostics's global workforce with approximately 71% of total employees, followed by Western Europe and East Asia.

MEDITE Cancer Diagnostics employees by region

RegionEmployees% of Total
North America21170.9%
Western Europe4715.7%
East Asia134.4%
Arab States82.5%
Northern Europe72.3%
Southeast Asia62.1%
Southern Europe41.3%
Pacific Islands10.5%
Central and Western Asia10.3%

Drill into city-level data, hiring trends by region, and historic geographic shifts.

Unlock Geographic Data

MEDITE Cancer Diagnostics Employee Count by Department (2026)

MEDITE Cancer Diagnostics's employee groups are Finance and Operations (38.7%), Engineering (36.7%), and Sales and Marketing (24.6%).

MEDITE Cancer Diagnostics employees by department

DepartmentEmployees% of Total
Finance and Operations12038.7%
Engineering11436.7%
Sales and Marketing7624.6%

Compare MEDITE Cancer Diagnostics's department mix to industry peers.

See Full Data

MEDITE Cancer Diagnostics Employee Salary by Region (2026)

MEDITE Cancer Diagnostics's average employee salary is $124,661 globally. Employees in North America receive the highest compensation. Pay is lowest in Southeast Asia, at a median of $9,000.

MEDITE Cancer Diagnostics median employee salary by region (USD)

RegionMedian Salary
North America$128,000
Northern Europe$93,000
Western Europe$73,000
Southern Europe$67,000
East Asia$36,000
Southeast Asia$9,000

Unlock salary by role, level, and city — and compare to MEDITE Cancer Diagnostics's industry peers.

Unlock Salary Data

MEDITE Cancer Diagnostics Job Openings and Hiring Trends (2023-2026)

Interactive chart of MEDITE Cancer Diagnostics annual active job postings from 2023 to 2026.
  • MEDITE Cancer Diagnostics had 58 active job postings in 2026, a 109.3% increase (+33) from 2025.
  • MEDITE Cancer Diagnostics had 25 active job postings in 2025, a 56.4% increase (+11) from 2024.
  • MEDITE Cancer Diagnostics had 14 active job postings in 2024, a 43.5% increase (+5) from 2023.
  • MEDITE Cancer Diagnostics had 9 active job postings in 2023, a 100.0% increase from 2022.
  • Hiring velocity in 2026: 24 new roles/month, up from 16 in 2025 and 10 in 2024.

MEDITE Cancer Diagnostics's hiring is accelerating: active job postings rose 109.3% in 2026 to 58, with new postings per month climbing from 7 in 2023 to 24 in 2026.

Track new postings per month, role-level demand, and hiring velocity vs. peers.

Unlock Hiring Data

MEDITE Cancer Diagnostics Employee Sentiment (2026)

Revelio Labs tracks employee sentiment across MEDITE Cancer Diagnostics's workforce based on public professional data. Overall sentiment is negative and has declined year over year in 2026.

Overall

NegativePositive

Unlock the full sentiment breakdown by department, tenure, and trend over time.

Unlock Sentiment

Similar Companies

Frequently Asked Questions About MEDITE Cancer Diagnostics

How fast is MEDITE Cancer Diagnostics growing?
In 2026, MEDITE Cancer Diagnostics's headcount grew 4.4% to 309 employees, up from 228 in 2025.
See the full headcount history
Where are MEDITE Cancer Diagnostics employees located?
Most MEDITE Cancer Diagnostics employees are based in North America (70.9% of headcount), followed by Western Europe and East Asia.
Explore where the workforce is based
What is the average salary at MEDITE Cancer Diagnostics?
The average employee salary at MEDITE Cancer Diagnostics is approximately $124.7k per year.
Analyze the salary distribution
How many new job postings does MEDITE Cancer Diagnostics open per year?
In Q1 2026, MEDITE Cancer Diagnostics opened 72 new job postings. In 2025, MEDITE Cancer Diagnostics opened 192 new job postings — about 16 per month.
Track hiring trends by role
When was MEDITE Cancer Diagnostics founded and where is it headquartered?
MEDITE Cancer Diagnostics was founded in 1998 and is headquartered in Orlando, Florida.
Compare MEDITE Cancer Diagnostics to industry peers

Speak with a workforce expert about MEDITE Cancer Diagnostics.

Book a Demo

See something that doesn't look right? Reach out and our team will review it.